RealStar® SARS-CoV-2 RT-PCR Kit 1.0 receives ANVISA approval
14th of May 2020
RealStar® SARS-CoV-2 RT-PCR Kit 1.0 approved by ANVISA (Reg. No. 80102512482)
altona Diagnostics Brasil LTDA, São Paulo, the brazilian subsidiary of altona Diagnostics GmbH, Germany, specialized in infectious diseases, obtained today, 14th of May 2020, the approval of the registration at ANVISA, the Brazilian Health Authority, for its real-time PCR kit to detect the RNA of SARS-CoV-2, causative agent of COVID-19.
Before the approval of ANVISA, the RealStar® SARS-CoV-2 RT-PCR Kit 1.0 has among others also obtained the Emergency Use Authorization of FDA, USA, and the approval in the European Union.
RealStar® SARS-CoV-2 RT-PCR Kit 1.0 is a real-time PCR test ready to use, which detects the lineage B betacoronavirus and specifically SARS-CoV-2. The kit forms part of the broad portfolio of tests of altona for infectious diseases including kits for tropical and emerging diseases, infections in immunosuppressed patients, infections caused by virus transmitted by blood transfusion, and viral and bacterial infections causing respiratory and enteric diseases.
Following the strategy of open platform, the PCR kit could be used on a variety of real-time PCR thermocyclers, frequently used in diagnostic laboratories.
For more information, please visit the SARS-CoV-2 webpage www.coronavirus-altona-dx.com/en/home.html of altona Diagnostics, and get the latest news.
RealStar® kit para enterovirus y rhinovirus se encuentra registrado en Argentina ante ANMATpdf
|Fecha de lanzamiento:||14.05.2020|